IP Library Granted Patent US 8,691,564
Granted Patent B2
US 8,691,564 · App. 13/531,101 · Granted Apr 8, 2014

Female specific insect expression system

Inventor: Helen Benes (Little Rock, AR)
Assignee: The Board of Trustees of the University of Arkansas
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,691,564
App. No.
13/531,101
Granted
Apr 8, 2014
Kind
B2
Abstract

The present invention provides an insect expression system that may be used to provide biological control of pest insects and control transmission of infectious diseases transmitted to the human population by insects.

Claims (16)

1. An expression system comprising:

(a) an enhancer sequence consisting of the nucleotide sequence as set forth in SEQ ID NO: 2;

(b) a heterologous promoter operably linked to the enhancer element of (a);

(c) one or more heterologous nucleic acid sequences for expression in a mosquito operably linked to the promoter in (b);

wherein, the enhancer element directs female-specific expression of the heterologous nucleic acid sequence at a level greater than six fold higher in female than in male mosquitoes.

2. The expression system of claim 1 , wherein the heterologous nucleic acid is selected from the group consisting of nucleic acids encoding a transactivation factor, a reporter, and an effector.

3. The expression system of claim 1 , wherein the effector is a cell death factor or a factor that provides a selective advantage to the mosquito.

4. The expression system of claim 1 , wherein the mosquito is the Aedes aegypti mosquito.

5. An expression system comprising:

(a) an enhancer sequence consisting of the nucleotide sequence as set forth in SEQ ID NO: 3;

(b) a heterologous promoter operably linked to the enhancer element of (a);

(c) one or more heterologous nucleic acid sequences for expression in a mosquito operably linked to the promoter in (b);

wherein, the enhancer element directs female-specific expression of the heterologous nucleic acid sequence at a level greater than six fold higher in female than in male mosquitoes.

6. The expression system of claim 5 , wherein the heterologous nucleic acid is selected from the group consisting of nucleic acids encoding a transactivation factor, a reporter, and an effector.

7. The expression system of claim 5 , wherein the effector is a cell death factor or a factor that provides a selective advantage to the mosquito.

8. The expression system of claim 5 , wherein the mosquito is the Aedes aegypti mosquito.

Assignments (2)
CONFIRMATORY LICENSE Recorded May 6, 2014
From: UNIV OF ARKANSAS FOR MED SCIS
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 032835/0475 →
CONFIRMATORY LICENSE Recorded Jun 29, 2012
From: UNIVERSITY OF ARKANSAS MED SCIS LTL ROCK
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 028466/0279 →
Continuity (2)
Continuation 12722968 · Mar 12, 2010
Related Publication 20120270311A1 · Oct 25, 2012